CIK 0001275187 · Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113146460
- Phone
- 5187981215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-26 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −314 | $8.80 | $3K | 59,552 |
| 2020-07-26 | Clemmer James C President and CEO | Shares withheld for taxes | −1,876 | $8.80 | $17K | 305,118 |
| 2020-07-26 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −283 | $8.80 | $2K | 23,983 |
| 2020-07-18 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −248 | $9.21 | $2K | 60,018 |
| 2020-07-18 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −152 | $9.21 | $1K | 59,866 |
| 2020-07-18 | Helsel Dave SVP Global Operations and R&D | Shares withheld for taxes | −207 | $9.21 | $2K | 23,501 |
| 2020-07-18 | Helsel Dave SVP Global Operations and R&D | Shares withheld for taxes | −155 | $9.21 | $1K | 23,348 |
| 2020-07-18 | Clemmer James C President and CEO | Shares withheld for taxes | −1,483 | $9.21 | $14K | 306,994 |
| 2020-07-18 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −224 | $9.21 | $2K | 24,342 |
| 2020-07-18 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −76 | $9.21 | $700 | 24,266 |
| 2020-07-17 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −354 | $9.46 | $3K | 60,266 |
| 2020-07-17 | Helsel Dave SVP Global Operations and R&D | Shares withheld for taxes | −254 | $9.46 | $2K | 23,708 |
| 2020-07-17 | Clemmer James C President and CEO | Shares withheld for taxes | −2,131 | $9.46 | $20K | 308,477 |
| 2020-07-17 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −262 | $9.46 | $2K | 24,566 |
| 2020-07-14 | Tarnoff Michael E Director | Grant or award | +15,323 | 15,323 | ||
| 2020-07-14 | Trowbridge Stephen A EVP and CFO | Grant or award | +15,121 | 60,620 | ||
| 2020-07-14 | Trowbridge Stephen A EVP and CFO | Grant or award · Performance Right | +30,242 | 30,242 | ||
| 2020-07-14 | Trowbridge Stephen A EVP and CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +44,510 | 44,510 | ||
| 2020-07-14 | Helsel Dave SVP Global Operations and R&D | Grant or award | +7,540 | 23,962 | ||
| 2020-07-14 | Helsel Dave SVP Global Operations and R&D | Grant or award · Performance Right | +15,081 | 15,081 |
Page 22 of 30 · 589 trades